NewSquare Capital LLC increased its position in shares of Clorox Co. (NYSE:CLX) by 15.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,729 shares of the company’s stock after buying an additional 493 shares during the period. NewSquare Capital LLC’s holdings in Clorox were worth $516,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in CLX. Checchi Capital Advisers LLC raised its stake in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Cleararc Capital Inc. raised its stake in shares of Clorox by 0.3% in the first quarter. Cleararc Capital Inc. now owns 3,163 shares of the company’s stock worth $399,000 after buying an additional 10 shares during the period. Mariner Wealth Advisors LLC raised its stake in shares of Clorox by 0.4% in the first quarter. Mariner Wealth Advisors LLC now owns 2,505 shares of the company’s stock worth $316,000 after buying an additional 10 shares during the period. Keel Point LLC raised its stake in shares of Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock worth $1,040,000 after buying an additional 37 shares during the period. Finally, DAVENPORT & Co LLC raised its stake in shares of Clorox by 3.4% in the second quarter. DAVENPORT & Co LLC now owns 3,039 shares of the company’s stock worth $421,000 after buying an additional 99 shares during the period. 70.17% of the stock is owned by institutional investors and hedge funds.

Shares of Clorox Co. (NYSE:CLX) traded up 0.63% during mid-day trading on Tuesday, reaching $123.44. The company had a trading volume of 1,120,012 shares. The company has a market capitalization of $15.98 billion, a PE ratio of 25.09 and a beta of 0.33. Clorox Co. has a 1-year low of $113.37 and a 1-year high of $140.47. The stock’s 50-day moving average price is $129.50 and its 200 day moving average price is $130.10.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The business earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.44 earnings per share. Equities analysts expect that Clorox Co. will post $5.49 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is presently 64.91%.

A number of equities research analysts have issued reports on the stock. B. Riley reaffirmed a “neutral” rating and set a $109.00 price objective on shares of Clorox in a report on Tuesday, August 9th. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, July 12th. Goldman Sachs Group Inc. reiterated a “neutral” rating and set a $130.00 target price on shares of Clorox in a research report on Thursday, August 4th. Citigroup Inc. increased their target price on Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a research report on Monday, August 8th. Finally, Jefferies Group reiterated a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $128.90.

In related news, EVP Laura Stein sold 38,882 shares of the business’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares in the company, valued at $6,387,096.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jon M. Balousek sold 5,136 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the sale, the senior vice president now owns 15,384 shares of the company’s stock, valued at $2,017,457.76. The disclosure for this sale can be found here. 2.09% of the stock is owned by insiders.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.